You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin with or without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis

Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis.

Date Reviewed: November 19, 2017

Measure Info

MIPS 332CMS 332
Measure Type: 
Process
Measure Steward: 
American Academy of Otolaryngology - Head and Neck Surgery
Clinical Topic Area: 
Sinusitis

Care Setting: 
Outpatient
Data Source: 
Registry

ACP does not support QPP measure 332: "Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin with or without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis." While it is clinically important to promote appropriate use of broad-spectrum antibiotics, numerator specifications do not align with Infectious Diseases Society of America (IDSA) clinical recommendations on treatment of acute, bacterial rhinosinusitis. IDSA recommends amoxicillin-clavulanate as the first line of treatment in patients diagnosed with bacterial sinusitis. Also, the measure specifications do not include exclusion criteria for patients who do not tolerate amoxicillin. About 30%-40% of patients are bacterial resistant to amoxicillin therapy alone. Developers should update the measure specifications to encourage prescription of amoxicillin-clavulanate as first-line therapy in patients diagnosed with bacterial sinusitis.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!